Discussion
People with Parkinson’s disease who switch from other formulations of levodopa to Crexont may experience improvements in daily symptom control, according to new data from an ongoing clinical trial. “Crexont substantially increased [good on] time, reduced [off time], and improved motor function in [Parkinson’s] patients across all therapy…
